resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
a05a7478-548d-4e6b-b7d0-17891a503e06,SNU-407,['Cell Line'],"The SNU-407 cell line is a colorectal carcinoma cell line established from a Korean cancer patient with a mutation in the beta-catenin gene at codon 41, resulting in a Thr to Ala amino acid change.","['Genomics', 'Cell line origin']",,,,https://doi.org/10.4143/crt.2005.37.1.1
a05a7478-548d-4e6b-b7d0-17891a503e06,SNU-407,['Cell Line'],"The SNU-407 cell line has been used in research on multidrug resistance, anticancer drug screening, microsatellite instability studies, gene expression analysis and other areas.",['Research applications'],,,,https://doi.org/10.4143/crt.2005.37.1.1
a05a7478-548d-4e6b-b7d0-17891a503e06,SNU-407,['Cell Line'],The SNU-407 cell line is available from the Korean Cell Line Bank (KCLB) for researchers.,['Resource availability'],,,,https://doi.org/10.4143/crt.2005.37.1.1
a05a7478-548d-4e6b-b7d0-17891a503e06,SNU-407,['Cell Line'],"The SNU-407 cell line exhibited resistance to the vinca alkaloids and anthracyclins, which is frequently due to expression of the P-glycoprotein drug efflux pump encoded by the MDR1 gene.","['Drug resistance', 'Gene expression']",,,,https://doi.org/10.4143/crt.2005.37.1.1
